Metraipolis › archive › dc_801f2d7e2ce8

TKT drives renal cell carcinoma progression through metabolic reprogramming and synergistic interaction with PKM2 — Europe PMC PMID:41253799

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41253799
DOI
10.1038/s41420-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-08T11:27:16.818Z
SHA-256 of the archived text
8a35fb513d77c6ffacbf3eaa7b5309058fe596490579a7eaaf184ebdffda0156
Stable URL of this page
https://metraipolis.com/documento/dc_801f2d7e2ce8

How to cite

TKT drives renal cell carcinoma progression through metabolic reprogramming and synergistic interaction with PKM2 — Europe PMC PMID:41253799 — Europe PMC (en), https://europepmc.org/article/MED/41253799 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_801f2d7e2ce8 (Metraipolis archive dc_801f2d7e2ce8, sha256 8a35fb513d77c6ffacbf3eaa7b5309058fe596490579a7eaaf184ebdffda0156)
BibTeX
@misc{dc801f2d7e2ce8,
  title = {TKT drives renal cell carcinoma progression through metabolic reprogramming and synergistic interaction with PKM2 — Europe PMC PMID:41253799},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41253799},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_801f2d7e2ce8; sha256 8a35fb513d77c6ffacbf3eaa7b5309058fe596490579a7eaaf184ebdffda0156},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41253799. Agents can read the archived copy with the MCP tool read_document.